09.09.25 -- Biopharma Manufacturing Outsourcing Is Flexible, Not Fractured

Join us, as Biologics US 2025 gathers North America's biopharma leaders to tackle challenges in antibody and ADC R&D. See how experts are using AI-assisted design, novel protein targets, and advanced conjugation strategies to drive effective therapeutics. Don't miss keynotes from Steve Turner and Ray Deshaies, GLIMPSE-1 human-first antibody insights from Wyatt McDonnell, and our Innovations & Breakthroughs Under the Stars Garden Party. Claim your free ticket.

Leaders discuss advancing equity through inclusive trial design, access planning, and global partnerships to overcome persistent health disparities and expand access to lifesaving therapies.

Explore the key aspects of lipid nanoparticle (LNP) development, including the essential downstream processes of Tangential Flow Filtration (TFF) and normal flow filtration.

Producing mRNA therapeutics requires navigating complex manufacturing challenges. A strategic partnership with an integrated CMO streamlines manufacturing processes and reduces costs.

Analytical assays aren't just important for quality control. Regulators expect them. These tips will help if you're just starting to build your analytical package.

Build a reliable, de-risked path to the clinic while avoiding unforeseen costs and compliance-related delays with advice from Suparna Sanyal, Ph.D., Head of Viral Vectors Commercial Development.

Learn about two independent suspension-adapted knockout cell lines (AC003 and AC010) that show greater than 2-fold improvement in AAV9 production capacity.

With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

Enhance the success of your research and cell therapy programs by sourcing PBMCs with proven functional performance and donor-specific insights.

Consider several gene editing technologies — TARGATT, Mad7, and Base Editing — and gain insights into their transformative applications in genetic engineering and therapeutic development.

Discover how a recent expansion into Western Pennsylvania is aiming to enable more biopharmaceutical firms to translate cutting-edge science and research into practical applications.

Find development and manufacturing capabilities designed with patient safety and centricity in mind, including drug product process and formulation development and process characterization support.

Committed to collaboration, CCS combines the technology, expertise, and capacity you need to bring your novel cell therapies from discovery to commercialization.

Translating mRNA sequence to a high-quality drug product presents a complex challenge. Learn how partnering with a single contract manufacturer can alleviate potential delays and risks.

Find specialized development and manufacture services for new biological modalities. Discover the benefits of choosing a CDMO with complete end-to-end services and in-house analytical capabilities.